Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Protein Purification

Principle and Setup: Harnessing the Power of the HA Tag Peptide

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic nine-amino acid sequence (YPYDVPDYA) derived from the epitope region of the human influenza virus hemagglutinin protein. As a molecular biology peptide tag, it is widely recognized for its specificity, high solubility, and competitive binding to Anti-HA antibodies. This HA tag peptide is a cornerstone of protein purification tags, enabling efficient detection, isolation, and elution of HA-tagged fusion proteins from complex lysates.

The HA peptide’s utility is rooted in its ability to serve as an epitope tag for protein detection. When genetically fused to a protein of interest, the hemagglutinin tag (HA tag) is recognized by high-affinity Anti-HA antibodies, facilitating downstream applications such as immunoprecipitation, Western blotting, and protein-protein interaction studies. Its high chemical purity (>98%, HPLC and MS verified) and impressive solubility profile (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) allow for seamless integration into diverse experimental buffers and conditions.

Step-by-Step Workflow and Protocol Enhancements

1. Construct Design: Incorporating the HA Tag

Begin by integrating the HA tag DNA sequence into your gene of interest, using standard cloning techniques. The short, non-immunogenic nature of the HA tag sequence (encoding YPYDVPDYA) minimizes interference with protein folding or function. Sequence verification ensures fidelity and optimal expression.

2. Expression and Cell Lysis

Express the HA-tagged protein in your chosen system (e.g., mammalian, yeast, or bacterial cells). Following induction, harvest cells and lyse under mild, non-denaturing conditions to preserve protein-protein interactions—critical when performing immunoprecipitation with Anti-HA antibody for interaction studies.

3. Immunoprecipitation and Competitive Elution

• Capture: Incubate clarified lysate with Anti-HA Magnetic Beads or conventional Anti-HA antibody-conjugated beads. The antibody binds the HA epitope, immobilizing the HA fusion protein and associated complexes.
• Washing: Wash beads thoroughly with a buffer compatible with protein integrity (e.g., PBS or TBS with 0.1% Tween-20), leveraging the HA tag’s high solubility to minimize nonspecific background.
• Elution: Add the synthetic HA peptide at a concentration of 1–2 mg/mL (or empirically optimized) to elute the HA-tagged protein via competitive binding to the Anti-HA antibody. The high solubility of the peptide ensures efficient displacement and recovery, even in high-yield scenarios.

This workflow is validated as a gold standard for reproducibility and specificity, as detailed in the review "Precision Tag for Protein Detection and Interaction Studies", which highlights the robust performance of the HA tag peptide in standard and advanced immunoprecipitation workflows.

4. Downstream Applications

The eluted HA fusion protein can be analyzed via SDS-PAGE, Western blot, mass spectrometry, or used in functional assays. For applications such as exosome pathway mapping or dynamic ubiquitination studies—as exemplified in the study by Wei et al.—high-purity HA tag peptides enable the isolation of intact protein complexes, facilitating the investigation of intricate cellular mechanisms such as ESCRT-independent exosome biogenesis.

Advanced Applications and Comparative Advantages

Empowering Protein-Protein Interaction Studies

The HA peptide is instrumental in dissecting complex protein interactions. For example, in studies of ubiquitin-mediated pathways in cancer research, the HA tag enables selective pulldown of target proteins and their interacting partners, as highlighted in "Redefining Translational Research: The Strategic Utility of HA Tag Peptides". Here, the Influenza Hemagglutinin epitope tag served as a molecular handle to unravel E3 ligase NEDD4L substrates in colorectal cancer, illustrating the translational power of the HA tag system.

High Solubility and Chemical Purity: Quantified Gains

Compared to other epitope tags, the Influenza Hemagglutinin (HA) Peptide stands out with its certified purity (>98%) and superior solubility (up to 100.4 mg/mL in ethanol). In practical terms, this means:

• Consistent, high-yield recovery of HA fusion proteins, even from low-abundance samples.
• Low background in immunoprecipitation with Anti-HA antibody, leading to clearer, more interpretable Western blot and mass spectrometry data.
• Compatibility with a broad spectrum of lysis and elution buffers, including those required for delicate protein-protein interaction studies.

This performance is corroborated in scenario-driven evaluations such as "Optimizing Protein Purification: Real-World Scenarios with HA Tag Peptides", which demonstrates how APExBIO’s HA peptide ensures workflow efficiency and reproducibility.

Versatility Across Experimental Platforms

Whether your focus is immunoprecipitation, chromatin immunoprecipitation (ChIP), or affinity purification, the HA tag sequence and its corresponding peptide offer unmatched versatility. The standardized ha tag nucleotide sequence and ha tag DNA sequence simplify construct design, while the peptide’s robust compatibility with various detection systems (colorimetric, chemiluminescent, or fluorescent) supports multiplexed and high-throughput applications.

Troubleshooting and Optimization Tips

Maximizing Yield and Specificity

• Elution Efficiency: If elution yields are suboptimal, ensure the peptide concentration is sufficient (≥1 mg/mL is a common starting point) and incubation time is adequate (30–60 minutes at 4°C, with gentle agitation). For particularly strong antibody-antigen interactions, consider increasing peptide concentration up to the solubility limit (≥46.2 mg/mL in water).
• Buffer Composition: The peptide’s high solubility enables use in a wide range of buffers. However, avoid high concentrations of detergents or chaotropes that may disrupt protein structure or antibody binding. For sensitive protein-protein interaction studies, use mild, non-denaturing buffers (e.g., 20 mM Tris, 150 mM NaCl, 0.1% NP-40).
• Protein Degradation: Add protease inhibitors during lysis and all subsequent steps to protect labile complexes.
• Bead Carryover: To minimize bead contamination, perform an additional wash after elution and use low-retention pipette tips.
• Storage: Store lyophilized peptide desiccated at -20°C. Avoid long-term storage of peptide solutions; prepare fresh aliquots as needed for each experiment.

Case Example: Troubleshooting Low Signal in Immunoprecipitation

Scenario: A user observes weak bands on Western blot following HA pulldown.
Resolution: Increase peptide elution concentration, verify antibody activity, and confirm the integrity of the HA tag by sequencing the fusion construct. As outlined in "Precision Tag for Protein Purification Workflows", using a highly pure and soluble HA peptide from APExBIO can resolve common sources of low recovery or background interference.

Future Outlook: Next-Generation Protein Tagging and Exosome Research

The strategic importance of the HA tag system continues to grow as molecular biology moves toward increasingly complex and high-throughput applications. The recent study on ESCRT-independent exosome pathways by Wei et al. underscores the need for tools that enable the precise isolation of tagged protein complexes from native cellular contexts. Leveraging the Influenza Hemagglutinin (HA) Peptide not only accelerates the mapping of intricate protein networks but also facilitates advances in translational research, such as the characterization of disease-relevant protein trafficking and ubiquitination events.

Looking ahead, innovations in tag design, antibody engineering, and buffer chemistry will further expand the utility of the HA tag peptide. Researchers can expect even greater sensitivity, specificity, and multiplexing capability—cementing the HA tag as a mainstay in the molecular toolkit.

Conclusion

The Influenza Hemagglutinin (HA) Peptide from APExBIO is a proven, high-purity solution for researchers demanding reliability and flexibility in protein detection, purification, and interaction studies. Whether your aim is to dissect molecular mechanisms in cancer, map protein trafficking pathways, or streamline complex immunoprecipitation workflows, this HA fusion protein elution peptide sets the standard for performance and reproducibility. For more information or to order, visit the Influenza Hemagglutinin (HA) Peptide product page.